Comparing Ericksonian Hypnotherapy and CBT for PTSD treatment
Neuropsychophysiological Comparison of Ericksonian Hypnotherapy and Cognitive Behavioral Therapy in Patients Diagnosed With Post-Traumatic Stress Disorder: A Protocol and Pilot Study of Two Armed Open Label Randomized Clinical Trial
This study is testing whether Ericksonian Hypnotherapy or Cognitive Behavioral Therapy (CBT) works better to help people aged 18-60 with Post-Traumatic Stress Disorder (PTSD) feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Uskudar University Academic / other |
| Locations | 1 site (İstanbul) |
| Trial ID | NCT06761716 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to compare the effectiveness of Ericksonian Hypnotherapy and Cognitive Behavioral Therapy (CBT) in treating individuals diagnosed with Post-Traumatic Stress Disorder (PTSD). Participants aged 18-60 will be randomly assigned to one of three groups: one receiving Ericksonian Hypnotherapy, another receiving CBT, and a control group with no intervention. The study will assess the impact of these therapies on PTSD symptoms and measure physiological responses such as brain activity, skin conductance, and heart rate at baseline and post-intervention. The goal is to determine if one therapy is more effective than the other in alleviating PTSD symptoms.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-60 diagnosed with PTSD who are not currently on psychiatric medication or undergoing other psychotherapeutic interventions.
Not a fit: Patients with severe psychiatric disorders, neurological conditions, or those currently using psychiatric medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into more effective therapeutic options for individuals suffering from PTSD.
How similar studies have performed: While both therapies have shown promise individually, this comparative approach is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Adults aged 18-60 years. Diagnosed with Post-Traumatic Stress Disorder (PTSD) based on DSM-5 criteria. No current psychiatric medication usage. Not undergoing any other psychotherapeutic intervention during the study period. Ability to attend all therapy sessions and assessments. Ability to provide written informed consent. No neurological disorders or cognitive impairments that could affect participation. Exclusion Criteria: Individuals under 18 or over 60 years of age. Current or past diagnosis of schizophrenia, bipolar disorder, or other severe psychiatric disorders. Acute risk of harm from engaging in trauma discussions. Use of psychiatric medication within the last 3 months. Ongoing participation in other psychotherapeutic interventions. History of substance abuse or dependence in the past 12 months. Known neurological disorders (e.g., epilepsy, traumatic brain injury). Inability to provide informed consent or comply with study procedures. Pregnancy or breastfeeding. Severe cardiovascular conditions that might interfere with physiological assessments.
Where this trial is running
İstanbul
- Üsküdar University — İstanbul, Turkey (Recruiting)
Study contacts
- Principal investigator: Selami Varol Ülker, Phd — Üsküdar University
- Study coordinator: Selami Varol Ülker, Phd
- Email: selamivarol.ulker@uskudar.edu.tr
- Phone: 00905364360941
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.